Phosphodiesterase-5 inhibitors and hearing impairment: a disproportionality analysis using the US food and drug administration adverse event reporting system
These findings highlight a significant correlation between PDE-5i use and HIAEs, emphasizing the need for careful evaluation in clinical practice and providing appropriate guidance to patients before initiating treatment.
Authors
- Bin Wu (ORCID: https://orcid.org/0000-0001-5313-5193)
- Bing-jie Xiao
- Min Luo (ORCID: https://orcid.org/0000-0001-9322-7279)
- Ruonan Gao (ORCID: https://orcid.org/0000-0002-7351-1907)
- Tianqi Liu (ORCID: https://orcid.org/0000-0002-1659-5139)
- Ronghai Cui
- Xiangtong Ye
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1080/14740338.2024.2386374
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.33
Funders
- National Key Research and Development Program of China